Mechanistic and Clinical Aspects of Renin-Angiotensin-Aldosterone System Blockade in the Prevention of Diabetes Mellitus and Cardiovascular Disease

2011 ◽  
Vol 17 (3) ◽  
pp. 430-440 ◽  
Author(s):  
Kenneth Hershon
Keyword(s):  
Diabetes Mellitus ◽  
Cardiovascular Disease ◽  
Clinical Aspects ◽  
Renin Angiotensin Aldosterone System ◽  
Renin Angiotensin ◽  
Prevention Of Diabetes

scholarly journals Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis

2014 ◽  
Vol 8 (1) ◽  
pp. 6-11 ◽  
Author(s):  
Yoshiyuki Morishita ◽  
Eiji Kusano ◽  
Daisuke Nagata
Keyword(s):  
Cardiovascular Disease ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Clinical Implication ◽  
Renin Angiotensin Aldosterone System ◽  
Renin Angiotensin ◽  
Beneficial Effects

The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effects of RAAS blockers in chronic kidney disease undergoing hemodialysis for cardiovascular disease.

Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus

2008 ◽  
Vol 5 (1) ◽  
pp. 59-66 ◽  
Author(s):  
Darren K McGuire ◽  
Jeffrey R Winterfield ◽  
Jason A Rytlewski ◽  
Ele Ferrannini
Keyword(s):  
Diabetes Mellitus ◽  
Renin Angiotensin Aldosterone System ◽  
Renin Angiotensin
Sign in / Sign up

Export Citation Format

Share Document